- Report
- August 2024
- 200 Pages
Global
From €3587EUR$3,869USD£3,000GBP
- Report
- August 2024
- 170 Pages
Global
From €2318EUR$2,500USD£1,939GBP
- Report
- June 2026
- 121 Pages
Mexico
From €3708EUR$3,999USD£3,101GBP
- Report
- April 2025
- 144 Pages
Global
From €3708EUR$3,999USD£3,101GBP
- Report
- January 2025
- 182 Pages
Global
From €4631EUR$4,995USD£3,874GBP
- Report
- March 2026
- 150 Pages
Canada
From €4497EUR$4,850USD£3,761GBP
- Report
- March 2026
- 180 Pages
China
From €4497EUR$4,850USD£3,761GBP
- Report
- March 2026
- 214 Pages
Germany
From €4497EUR$4,850USD£3,761GBP
- Report
- March 2026
- 248 Pages
India
From €4497EUR$4,850USD£3,761GBP
- Report
- February 2026
- 150 Pages
India
From €4497EUR$4,850USD£3,761GBP
- Report
- February 2026
- 173 Pages
Canada
From €4497EUR$4,850USD£3,761GBP
- Report
- February 2026
- 182 Pages
China
From €4497EUR$4,850USD£3,761GBP
- Report
- February 2026
- 175 Pages
India
From €4497EUR$4,850USD£3,761GBP
- Report
- December 2025
- 150 Pages
Germany
From €4497EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
India
From €4497EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
Japan
From €4497EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
Japan
From €4497EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
China
From €4497EUR$4,850USD£3,761GBP
- Report
- September 2025
- 150 Pages
Global
From €4497EUR$4,850USD£3,761GBP
- Report
- September 2025
- 150 Pages
Global
From €4497EUR$4,850USD£3,761GBP

The Vaccine Adjuvant market is a subset of the Vaccines market, which is composed of products that are used to enhance the effectiveness of vaccines. Vaccine adjuvants are substances that are added to vaccines to increase the body's immune response to the vaccine. Adjuvants can be either natural or synthetic, and can be used to increase the potency of a vaccine, reduce the amount of antigen needed, or to extend the duration of the vaccine's effectiveness. Vaccine adjuvants are used in a variety of vaccines, including those for influenza, hepatitis, and human papillomavirus.
Some companies in the Vaccine Adjuvant market include GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more